Neurogene Statistics
Share Statistics
Neurogene has 14.26M
shares outstanding. The number of shares has increased by 15.02%
in one year.
| Shares Outstanding | 14.26M |
| Shares Change (YoY) | 15.02% |
| Shares Change (QoQ) | -28.84% |
| Owned by Institutions (%) | 93.57% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 7,211 |
| FTD / Avg. Volume | 2.58% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -5.34 and the forward
PE ratio is -2.07.
Neurogene's PEG ratio is
-0.09.
| PE Ratio | -5.34 |
| Forward PE | -2.07 |
| PS Ratio | 434.14 |
| Forward PS | 2.2 |
| PB Ratio | 1.29 |
| P/FCF Ratio | -5.62 |
| PEG Ratio | -0.09 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Neurogene.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.84,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 20.84 |
| Quick Ratio | 20.84 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.17 |
| Interest Coverage | -6883.75 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $8,644.86 |
| Profits Per Employee | $-702,280.37 |
| Employee Count | 107 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -53.45% in the
last 52 weeks. The beta is 1.56, so Neurogene's
price volatility has been higher than the market average.
| Beta | 1.56 |
| 52-Week Price Change | -53.45% |
| 50-Day Moving Average | 14.2 |
| 200-Day Moving Average | 28.71 |
| Relative Strength Index (RSI) | 63.51 |
| Average Volume (20 Days) | 279,627 |
Income Statement
In the last 12 months, Neurogene had revenue of 925K
and earned -75.14M
in profits. Earnings per share was -4.43.
| Revenue | 925K |
| Gross Profit | -2.32M |
| Operating Income | -82.61M |
| Net Income | -75.14M |
| EBITDA | -71.89M |
| EBIT | -75.13M |
| Earnings Per Share (EPS) | -4.43 |
Full Income StatementBalance Sheet
The company has 136.59M in cash and 12.43M in
debt, giving a net cash position of 124.16M.
| Cash & Cash Equivalents | 136.59M |
| Total Debt | 12.43M |
| Net Cash | 124.16M |
| Retained Earnings | -262.3M |
| Total Assets | 335.73M |
| Working Capital | 300.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -70.6M
and capital expenditures -808K, giving a free cash flow of -71.41M.
| Operating Cash Flow | -70.6M |
| Capital Expenditures | -808K |
| Free Cash Flow | -71.41M |
| FCF Per Share | -4.07 |
Full Cash Flow StatementMargins
Gross margin is -251.03%, with operating and profit margins of -8930.27% and -8123.68%.
| Gross Margin | -251.03% |
| Operating Margin | -8930.27% |
| Pretax Margin | -8123.68% |
| Profit Margin | -8123.68% |
| EBITDA Margin | -7771.35% |
| EBIT Margin | -8930.27% |
| FCF Margin | -7720.11% |
